HNRPR |
HNRPR: Heterogeneous nuclear ribonucleoprotein R |
EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
3.83 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
3.827 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
3.827 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
LSP1 |
|
3.815 |
Evidence |
|
CA2 |
CA2: Carbonic anhydrase 2 |
STOM |
IPI00377081 |
3.815 |
Evidence |
|
EMP3 |
EMP3, YMP: Epithelial membrane protein 3 |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
3.815 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
MCM10 |
IPI00164354 |
3.815 |
Evidence |
|
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
ESPL1 |
IPI00397474 |
3.815 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
LSP1 |
|
3.815 |
Evidence |
|
GNB2L1 |
Lung cancer oncogene 7 |
EIF3S12 |
EIF3S12, ARG134, HSPC029, MSTP001, PTD001: Eukaryotic translation initiation fac |
3.815 |
Evidence |
|
PES1 |
PES1: Pescadillo homolog 1 |
SERBP1 |
IPI00412714 |
3.815 |
Evidence |
|
MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
KIAA0101 |
PAF, KIAA0101, L5, NS5ATP9: PCNA-associated factor |
3.815 |
Evidence |
|
KIAA0101 |
PAF, KIAA0101, L5, NS5ATP9: PCNA-associated factor |
CCNB1 |
Cyclin B1 |
3.815 |
Evidence |
|
CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CDCA8 |
CDCA8, PESCRG3: Borealin |
3.815 |
Evidence |
|
DUSP14 |
DUSP14, MKP6: Dual specificity protein phosphatase 14 |
ACVRL1 |
ACVRL1, ACVRLK1, ALK1: Serine/threonine-protein kinase receptor R3 precursor |
3.815 |
Evidence |
|
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
DUSP21 |
DUSP21, LMWDSP21: Dual specificity protein phosphatase 21 |
3.815 |
Evidence |
|
ACVRL1 |
ACVRL1, ACVRLK1, ALK1: Serine/threonine-protein kinase receptor R3 precursor |
DUSP21 |
DUSP21, LMWDSP21: Dual specificity protein phosphatase 21 |
3.815 |
Evidence |
|
SYT5 |
SYT5: Synaptotagmin-5 |
CACNA1B |
CACNA1B, CACH5, CACNL1A5: Voltage-dependent N-type calcium channel subunit alpha |
3.815 |
Evidence |
|
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
3.81 |
Evidence |
|
SOS1 |
SOS1: Son of sevenless homolog 1 |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
3.81 |
Evidence |
|
GFAP |
GFAP: Glial fibrillary acidic protein |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
3.795 |
Evidence |
|
DSTN |
DSTN, ACTDP, DSN: Destrin |
MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
3.795 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
3.795 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
3.795 |
Evidence |
|
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
3.795 |
Evidence |
|